tallimustine has been researched along with benzofurans in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisiach, M; D'Incalci, M; Filippini, C; Tagliabue, G; Ubezio, P | 1 |
| Woynarowski, JM | 1 |
1 review(s) available for tallimustine and benzofurans
| Article | Year |
|---|---|
Targeting critical regions in genomic DNA with AT-specific anticancer drugs.
Topics: Antineoplastic Agents; Base Sequence; Benzofurans; Binding Sites; Cyclohexanecarboxylic Acids; Cyclohexenes; Distamycins; DNA Damage; DNA, Neoplasm; Drug Design; Duocarmycins; Genome, Human; Humans; Indoles; Nitrogen Mustard Compounds; Tandem Repeat Sequences; Tumor Cells, Cultured; Urea | 2002 |
1 other study(ies) available for tallimustine and benzofurans
| Article | Year |
|---|---|
Hematopoietic toxicity and cell cycle perturbations induced by new DNA minor groove-alkylating agents.
Topics: Animals; Antineoplastic Agents, Alkylating; Benzofurans; Body Weight; Bone Marrow Cells; Cell Cycle; Cell Division; Distamycins; Duocarmycins; Flow Cytometry; Indoles; Leukocyte Count; Male; Melphalan; Mice; Mice, Inbred Strains; Neutropenia; Nitrogen Mustard Compounds; Survival Rate; Thrombocytopenia | 1997 |